TWD 46.3
(-0.43%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 424.09 Million TWD | 13.4% |
2022 | 373.99 Million TWD | 43.28% |
2021 | 261.02 Million TWD | 21.68% |
2020 | 214.52 Million TWD | -1.27% |
2019 | 217.27 Million TWD | 19.01% |
2018 | 182.56 Million TWD | 13.9% |
2017 | 160.28 Million TWD | 18.8% |
2016 | 134.91 Million TWD | 47.4% |
2015 | 91.53 Million TWD | -4.72% |
2014 | 96.07 Million TWD | -10.39% |
2013 | 107.2 Million TWD | 5.56% |
2012 | 101.56 Million TWD | 99.24% |
2011 | 50.97 Million TWD | -20.97% |
2010 | 64.49 Million TWD | -18.39% |
2009 | 79.02 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 87.61 Million TWD | -14.57% |
2024 Q2 | 116.19 Million TWD | 32.62% |
2023 Q3 | 108.62 Million TWD | -6.54% |
2023 Q1 | 96.69 Million TWD | -11.98% |
2023 Q2 | 116.21 Million TWD | 20.19% |
2023 FY | 424.09 Million TWD | 13.4% |
2023 Q4 | 102.55 Million TWD | -5.58% |
2022 Q3 | 107.74 Million TWD | 18.93% |
2022 Q1 | 65.8 Million TWD | -4.74% |
2022 FY | 373.99 Million TWD | 43.28% |
2022 Q4 | 109.85 Million TWD | 1.96% |
2022 Q2 | 90.59 Million TWD | 37.66% |
2021 Q2 | 63.3 Million TWD | 5.36% |
2021 Q4 | 69.08 Million TWD | 0.78% |
2021 Q1 | 60.08 Million TWD | -3.69% |
2021 FY | 261.02 Million TWD | 21.68% |
2021 Q3 | 68.55 Million TWD | 8.29% |
2020 Q4 | 62.38 Million TWD | 16.15% |
2020 Q1 | 45.19 Million TWD | -21.06% |
2020 Q2 | 53.23 Million TWD | 17.8% |
2020 Q3 | 53.71 Million TWD | 0.89% |
2020 FY | 214.52 Million TWD | -1.27% |
2019 Q4 | 57.25 Million TWD | -1.65% |
2019 Q3 | 58.2 Million TWD | -9.8% |
2019 FY | 217.27 Million TWD | 19.01% |
2019 Q1 | 37.28 Million TWD | -15.59% |
2019 Q2 | 64.53 Million TWD | 73.08% |
2018 Q3 | 50.32 Million TWD | 5.9% |
2018 Q2 | 47.52 Million TWD | 17.19% |
2018 Q4 | 44.16 Million TWD | -12.23% |
2018 FY | 182.56 Million TWD | 13.9% |
2018 Q1 | 40.55 Million TWD | 3.34% |
2017 Q2 | 43.81 Million TWD | 22.99% |
2017 FY | 160.28 Million TWD | 18.8% |
2017 Q3 | 41.59 Million TWD | -5.07% |
2017 Q1 | 35.62 Million TWD | -6.12% |
2017 Q4 | 39.24 Million TWD | -5.66% |
2016 Q4 | 37.94 Million TWD | 4.97% |
2016 Q2 | 34.49 Million TWD | 31.08% |
2016 Q1 | 26.31 Million TWD | 63.98% |
2016 Q3 | 36.15 Million TWD | 4.8% |
2016 FY | 134.91 Million TWD | 47.4% |
2015 Q1 | 21.77 Million TWD | 43.74% |
2015 Q2 | 26.48 Million TWD | 21.6% |
2015 Q3 | 27.22 Million TWD | 2.8% |
2015 Q4 | 16.05 Million TWD | -41.04% |
2015 FY | 91.53 Million TWD | -4.72% |
2014 FY | 96.07 Million TWD | -10.39% |
2014 Q2 | 26.08 Million TWD | -8.92% |
2014 Q1 | 28.63 Million TWD | -4.11% |
2014 Q4 | 15.15 Million TWD | -42.18% |
2014 Q3 | 26.2 Million TWD | 0.48% |
2013 Q1 | 21.51 Million TWD | -13.68% |
2013 Q3 | 25.84 Million TWD | -13.84% |
2013 Q4 | 29.86 Million TWD | 15.56% |
2013 FY | 107.2 Million TWD | 5.56% |
2013 Q2 | 29.99 Million TWD | 39.38% |
2012 Q2 | - TWD | 0.0% |
2012 Q4 | 24.92 Million TWD | -3.6% |
2012 Q3 | 25.85 Million TWD | 0.0% |
2012 FY | 101.56 Million TWD | 99.24% |
2011 Q4 | - TWD | 0.0% |
2011 FY | 50.97 Million TWD | -20.97% |
2011 Q2 | - TWD | 0.0% |
2010 FY | 64.49 Million TWD | -18.39% |
2010 Q4 | - TWD | 0.0% |
2009 FY | 79.02 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 755.56 Million TWD | 43.87% |
SciVision Biotech Inc. | 512.49 Million TWD | 17.249% |
Bionime Corporation | 715.65 Million TWD | 40.74% |
Pegavision Corporation | 3.57 Billion TWD | 88.124% |
Visco Vision Inc. | 857.15 Million TWD | 50.523% |